Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19
- PMID: 33461503
- PMCID: PMC7812569
- DOI: 10.1186/s12879-021-05792-7
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19
Abstract
Background: The lack of knowledge regarding the pathogenesis and host immune response during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we longitudinally investigated the dynamic changes in peripheral blood lymphocyte subsets and parallel changes in cytokine levels in COVID-19 patients with different disease severities to further address disease pathogenesis.
Methods: A total of 67 patients (10 moderate, 38 severe and 19 critical cases) with COVID-19 admitted to a tertiary care hospital in Wuhan from February 8th to April 6th, 2020 were retrospectively studied. Dynamic data of lymphocyte subsets and inflammatory cytokines were collected.
Results: On admission, compared with moderate cases, severe and critical cases showed significantly decreased levels of total lymphocytes, T lymphocytes, CD4+ T cells, CD8+ T cells, B cells and NK cells. IL-6 and IL-10 were significantly higher in the critical group. During the following hospitalization period, most of the lymphocyte subsets in the critical group began to recover to levels comparable to those in the severe group from the fourth week after illness onset, except for NK cells, which recovered after the sixth week. A sustained decrease in the lymphocyte subsets and an increase in IL-6 and IL-10 were observed in the nonsurvivors until death. There was a strong negative correlation between IL-6 and IL-10 and total lymphocytes, T lymphocytes, CD4+ T cells, CD8+ T cells and NK cells.
Conclusions: A sustained decrease in lymphocyte subsets, especially CD4+ T cells and NK cells, interacting with proinflammatory cytokine storms was associated with severe disease and poor prognosis in COVID-19.
Keywords: COVID-19; Cytokine storm; Dynamic changes; Lymphocyte subsets; SARS-CoV-2.
Conflict of interest statement
All the authors declare no competing interests.
Figures
Similar articles
-
Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12536-12544. doi: 10.26355/eurrev_202012_24051. Eur Rev Med Pharmacol Sci. 2020. PMID: 33336774
-
Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.Diabetes Res Clin Pract. 2020 Sep;167:108341. doi: 10.1016/j.diabres.2020.108341. Epub 2020 Jul 22. Diabetes Res Clin Pract. 2020. PMID: 32707212 Free PMC article.
-
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.Virol J. 2021 Jun 12;18(1):126. doi: 10.1186/s12985-021-01597-x. Virol J. 2021. PMID: 34118952 Free PMC article.
-
Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.Eur Rev Med Pharmacol Sci. 2021 Aug;25(15):5057-5062. doi: 10.26355/eurrev_202108_26463. Eur Rev Med Pharmacol Sci. 2021. PMID: 34355378 Review.
-
Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?Front Immunol. 2020 Dec 1;11:607069. doi: 10.3389/fimmu.2020.607069. eCollection 2020. Front Immunol. 2020. PMID: 33335532 Free PMC article. Review.
Cited by
-
Contrasting mechanistic susceptibilities of hematopoietic and endothelial stem-progenitor cells in respective pathogeneses of HIV-1 and SARS-CoV-2 infections.Front Cell Dev Biol. 2023 Dec 6;11:1296986. doi: 10.3389/fcell.2023.1296986. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38155835 Free PMC article.
-
Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort.Front Cell Infect Microbiol. 2023 Oct 30;13:1288914. doi: 10.3389/fcimb.2023.1288914. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37965255 Free PMC article.
-
Host Response Changes and Their Association with Mortality in COVID-19 Patients with Lymphopenia.Am J Respir Crit Care Med. 2024 Feb 15;209(4):402-416. doi: 10.1164/rccm.202305-0890OC. Am J Respir Crit Care Med. 2024. PMID: 37948687 Free PMC article.
-
Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system.Front Med (Lausanne). 2023 Jun 28;10:1208866. doi: 10.3389/fmed.2023.1208866. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37448794 Free PMC article. Review.
-
Immunomodulation Effect of Convalescent Plasma Therapy in Severe - Critical COVID-19 Patients.Open Access Emerg Med. 2023 Apr 24;15:109-118. doi: 10.2147/OAEM.S405555. eCollection 2023. Open Access Emerg Med. 2023. PMID: 37124663 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
